Goldman Says Global Stock Markets Are Nowhere Near Risky Bubble

Published 22/03/2021, 11:28
© Bloomberg. A health worker administers the Moderna Inc. Covid-19 vaccine to a visitor at a Covid-19 vaccination center in Rome, Italy, on Wednesday, March 17, 2021. Europe's biggest countries, including Germany and France, suspended use of AstraZeneca Plc's Covid-19 vaccine amid a growing health scare that's creating yet another delay for the European Union's inoculation campaign.
US500
-
GS
-

(Bloomberg) -- While equities across major markets are hovering around record highs, Goldman Sachs Group Inc (NYSE:GS). strategists say many of the characteristics of a dangerous bubble are absent from global stocks.

Typical signs of systemic risk, such as increased leverage in the private sector and a collapse in savings, aren’t present, the strategists led by Peter Oppenheimer wrote in a report to clients on Monday. Moreover, the rally is unfolding against the backdrop of market concentration in companies that are fast-growing, generate cash and transform their industry, such as major technology businesses, they added.

“There are signs of complacency and heightened optimism in the market,” the Goldman strategists wrote in the 46-page report titled “Bubble Puzzle.” “Nevertheless, the fundamental factors that drive the market and the early stage of the economic cycle would suggest that we are far away from a bubble or bear market.”

European stocks rose last week to their highest in a year, despite prolonged lockdowns and delays in the continent’s vaccination rollout, which could delay a nascent recovery from the steepest recession in memory. In the U.S., the S&P 500 rose to another record high last week.

Still, not everything is fine. The analysts see “pockets of exuberance,” while “high valuations imply lower longer-term returns.”

©2021 Bloomberg L.P.

© Bloomberg. A health worker administers the Moderna Inc. Covid-19 vaccine to a visitor at a Covid-19 vaccination center in Rome, Italy, on Wednesday, March 17, 2021. Europe's biggest countries, including Germany and France, suspended use of AstraZeneca Plc's Covid-19 vaccine amid a growing health scare that's creating yet another delay for the European Union's inoculation campaign.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.